This study aims to assess the impact of a low FODMAP diet (LFD) on gastrointestinal symptoms and nutritional status in individuals diagnosed with small intestinal bacterial overgrowth (SIBO). Participants were randomly assigned to either an intervention group or a control group following completion of antibiotic therapy. The intervention group followed a LFD, while the control group followed a normal diet, in accordance with the principles of rational nutrition. Gastrointestinal symptoms, nutritional status, and quality of life were assessed using questionnaires, dietary records, anthropometric measurements, and blood biochemical parameters.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Gastrointestinal Adverse Symptoms Assessment Questionnaire (GASAQ) total score
Timeframe: 12 weeks
Nutritional status - Mini Nutritional Assessment (MNA)
Timeframe: 12 weeks
Nutritional status - Blood biochemical parameters (Serum vitamin D concentration)
Timeframe: 12 weeks
Nutritional status - Blood biochemical parameters (Serum folate concentration)
Timeframe: 12 weeks
Nutritional status - Blood biochemical parameters (Iron status parameters)
Timeframe: 12 weeks
Nutritional status - Blood biochemical parameters (Serum albumin concentration)
Timeframe: 12 weeks
Nutritional status - Anthropometric parameters (body weight)
Timeframe: 12 weeks
Nutritional status - Anthropometric parameters (body mass index (BMI)
Timeframe: 12 weeks
Nutritional status - anthropometric parameters (body fat percentage)
Timeframe: 12 weeks